Delivery of sgFABP5‐loaded lipid nanoparticles (Lips) to HCC‐LM3 and SK‐HEP1 cells led to a marked reduction in FABP5 expression (Figure 2M). The gene discussed is FABP5; the disease is hepatocellular carcinoma.